Answers are grounded in this paper and cite their sources.
Pilot study demonstrates predictive validity of gait biomarkers for cognitive decline in Alzheimer's disease and mild cognitive impairment.
To validate a clinical decision support tool integrating dual-task gait biomarkers with cognitive assessment and evaluate predictive validity for 6-month cognitive decline progression.
No takes yet. Share an insight, caveat, or question.
Doshi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: